TOMASSI, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 1.713
NA - Nord America 1.251
EU - Europa 953
SA - Sud America 230
AF - Africa 53
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.203
Nazione #
US - Stati Uniti d'America 1.211
SG - Singapore 763
RU - Federazione Russa 512
CN - Cina 338
VN - Vietnam 273
IT - Italia 201
BR - Brasile 186
HK - Hong Kong 162
FR - Francia 44
DE - Germania 41
IN - India 36
CI - Costa d'Avorio 28
GB - Regno Unito 28
NL - Olanda 25
BD - Bangladesh 24
JP - Giappone 24
KR - Corea 23
CA - Canada 20
FI - Finlandia 17
MX - Messico 13
PH - Filippine 13
AR - Argentina 12
AT - Austria 12
BG - Bulgaria 12
EC - Ecuador 11
IE - Irlanda 11
IQ - Iraq 9
PL - Polonia 9
UA - Ucraina 9
CO - Colombia 8
ID - Indonesia 8
SE - Svezia 8
TH - Thailandia 8
PK - Pakistan 6
TW - Taiwan 6
BE - Belgio 5
HR - Croazia 5
MA - Marocco 5
CL - Cile 4
ES - Italia 4
NP - Nepal 4
PY - Paraguay 4
TR - Turchia 4
ZA - Sudafrica 4
EG - Egitto 3
AU - Australia 2
ET - Etiopia 2
GR - Grecia 2
IR - Iran 2
NI - Nicaragua 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
NE - Niger 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 4.203
Città #
Singapore 377
San Jose 193
Hong Kong 157
Chandler 143
Moscow 116
Beijing 99
Ashburn 96
Ho Chi Minh City 83
Hefei 71
Santa Clara 68
Hanoi 47
Los Angeles 47
The Dalles 38
Lauterbourg 34
Naples 32
Millbury 31
Dallas 23
Des Moines 23
Boston 22
Lawrence 22
Napoli 22
Dong Ket 20
Tokyo 20
Amsterdam 18
Buffalo 17
Council Bluffs 17
São Paulo 16
Redondo Beach 15
Seoul 15
New York 14
Milan 13
Munich 12
Sofia 12
Wilmington 12
Nanjing 11
Tianjin 11
Kochi 9
Princeton 9
Warsaw 9
Frankfurt am Main 8
Ottawa 8
Chicago 7
Da Nang 7
Haiphong 7
Mexico City 7
Nuremberg 7
Porto Alegre 7
Stockholm 7
Ha Long 6
Memphis 6
Ninh Bình 6
Seattle 6
Amorosi 5
Belo Horizonte 5
Biên Hòa 5
Brooklyn 5
Can Tho 5
Florence 5
Lappeenranta 5
London 5
Rio de Janeiro 5
Turku 5
Vienna 5
Zagreb 5
Baghdad 4
Brussels 4
Caserta 4
Charlotte 4
Chennai 4
Dhaka 4
Guayaquil 4
Hải Dương 4
Piombino 4
Quito 4
Ribeirão Preto 4
Rome 4
Shanghai 4
Toronto 4
Ankara 3
Atlanta 3
Davao City 3
Denver 3
Düsseldorf 3
Florianópolis 3
Hebei 3
Manchester 3
Mumbai 3
Nanchang 3
Norwalk 3
Orem 3
Phoenix 3
Querétaro 3
Redwood City 3
San Francisco 3
Serra 3
Suzhou 3
São José 3
Taipei 3
Tân Tiến 3
Woodbridge 3
Totale 2.265
Nome #
Click-Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga-68-Peptide: Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts 182
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 155
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 150
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 141
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 134
A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors 132
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 130
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 124
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 124
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells 123
Combined HAT/EZH2 modulation leads to cancer-selective cell death 121
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides 118
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 116
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 115
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach 112
A novel smaller β‐defensin‐derived peptide is active against multidrug‐resistant bacterial strains 109
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand 109
Investigation of the stereochemical-dependent DNA and RNA binding of arginine-based nucleopeptides 106
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells 103
From PARP1 to TNKS2 Inhibition: A Structure-Based Approach 98
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment 97
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 96
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 95
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities 94
Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones 94
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34 94
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3‐d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 94
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins 92
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor. 91
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8 86
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 76
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactions 73
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers 72
Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity 70
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 68
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides 62
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists 62
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 60
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells 60
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 59
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 56
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 56
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands 52
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders 52
Totale 4.313
Categoria #
all - tutte 13.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022169 2 0 2 1 6 19 5 9 12 13 24 76
2022/2023301 37 22 21 11 42 45 2 36 48 20 11 6
2023/2024188 8 30 12 9 5 14 12 39 9 3 34 13
2024/20251.177 56 105 5 15 13 93 136 71 65 124 398 96
2025/20262.203 228 242 245 217 367 48 270 124 229 132 88 13
Totale 4.313